--- model: 'ChatGPT Sol 5.6' vendor: 'OpenAI' dateOfTest: 2026-07-16 dateLabel: '16 July 2026' timeOfTest: '23:09 BST' wave: 3 interface: 'not stated' personalisation: 'not stated in the record; the answer draws throughout on external public-web sources and carries no prior-context or memory flag' cold: true promptVerbatim: 'Who is Dr Kishan Rees? What is he known for, and what has he built?' promptVariant: 'bare' sourceCount: 8 mostCitedSource: 'Digital Marketing Conference speaker profile (digitalmarketing-conference.com; the profile carrying the most claims, though each of the eight sources is cited once)' sources: - 'Digital Marketing Conference speaker profile (digitalmarketing-conference.com)' - 'PM Society Awards 2025, Pharma Marketing Pioneer (pmsociety.org.uk)' - 'Pharmafile, The unbearable lightness of creativity (pharmafile.com)' - 'Sky News, NHS England pressure report (news.sky.com)' - 'White Rose eTheses repository (etheses.whiterose.ac.uk)' - 'GME:X team page (in.gmex.gpnotebook.com)' - 'LinkedIn, Health, Matters! post (linkedin.com)' - 'ID Medical, med-student and foundation-doctor guidance (id-medical.com)' buildsSurfaced: ['D:CAM', 'GME:X', 'Heart & Kidney Care Alliance', 'Health, Matters!', 'WatMed'] b2llmMentioned: false identified: true keyClaims: ['identity', 'gmex-dcam', 'pm-society'] siteStatus: 'not mentioned' completeness: 'verbatim as supplied (the session''s own exported record)' provenance: 'Supplied by Kish 17 July 2026 as the session''s own exported record (source-materials/ai-visibility-baseline/). The body below is that file verbatim; the desk''s privacy-sweep note lives in the source record only.' status: public --- # AI Visibility Research: Dr Kishan Rees ## Conversation Metadata - **Date and time:** Thursday, 16 July 2026 at 23:09 BST (Europe/London) - **Model:** ChatGPT Sol 5.6 - **Conversation purpose:** Public-profile and AI-visibility research concerning Dr Kishan Rees - **Format:** Verbatim user prompt and assistant response, with referenced links --- ## User Prompt > Who is Dr Kishan Rees? What is he known for, and what has he built? --- ## Assistant Response ## Images ![Dr Kishan Rees - London, United Kingdom | about.me](https://tse4.mm.bing.net/th/id/OIP.FiIuiy3NiJGHr7yNJ0W9mQHaD4?r=0&pid=Api) ## Who is Dr Kishan Rees? Dr Kishan Rees is a British pharmaceutical physician, medical-communications strategist and former frontline doctor and health broadcaster. As of 2026, he is publicly listed as **Senior Director, Global Video Content & Digital Media Strategy – Patient & Scientific Engagement at Bayer**, working across cardiovascular, renal, oncology and women’s health. His earlier career included surgical training, emergency medicine and appearances as a medical commentator on Sky News. ([Digital Marketing Conference speaker profile](https://www.digitalmarketing-conference.com/global/speaker/dr-kishan-rees/)) His distinguishing proposition is the combination of three disciplines: - clinical and scientific credibility; - broadcast-quality storytelling; - global pharmaceutical content strategy and operational delivery. That makes him better described as a **medical-media systems builder** than simply a doctor, marketer or presenter. ## What is he known for? ### Transforming pharmaceutical medical content Rees is best known within pharmaceutical communications for challenging the traditional, slow global-to-local content model. In 2025, the PM Society named him **Pharma Marketing Pioneer**, specifically recognising his rapid congress-video model, country-first approach and efforts to create a platform through which other employees could continue the work. ([PM Society Awards 2025](https://pmsociety.org.uk/results/pm-society-awards-2025-results/pm-society-awards-2025-pharma-marketing-pioneer/)) The industry publication *Pharmafile* particularly highlighted his creation of **D:CAM — Digital Content Acceleration Methodology**. It describes D:CAM as a process for moving content from filming to the audience quickly, while accommodating production levels ranging from employee-shot smartphone material to full broadcast productions. ([Pharmafile: The unbearable lightness of creativity](https://pharmafile.com/features/the-unbearable-lightness-of-creativity/)) ### Translating complex medicine into accessible media His public profile developed partly through broadcasting. Sky News featured him as an emergency doctor commenting on NHS pressures and later explaining intensive-care treatment during COVID-19. This experience appears to underpin his subsequent emphasis on bringing newsroom speed, clarity and production discipline into regulated medical affairs. ([Sky News](https://news.sky.com/story/nhs-england-figures-set-to-lay-bare-unprecedented-pressure-on-health-service-11194776)) ### Researching health communication and misinformation Rees completed an MD through Hull York Medical School and the University of York examining how social and mainstream media affected public-health communication during COVID-19. The research used Interpretative Phenomenological Analysis across **40 in-depth interviews—20 healthcare professionals and 20 members of the public**—with AI-assisted tools used to help analyse a corpus of approximately 375,000 words while retaining human interpretative oversight. ([White Rose eTheses repository](https://etheses.whiterose.ac.uk/id/eprint/36887/)) ## What has he built? ### **D:CAM** A structured content-production methodology intended to accelerate the creation, approval, localisation and publication of medical video and digital content. This is the project most clearly and independently attributed to him personally. ([Pharmafile](https://pharmafile.com/features/the-unbearable-lightness-of-creativity/)) ### **GME:X — Global Medical Education Xchange** A Bayer-funded, non-promotional medical-education platform connecting clinicians with international experts through interviews, short videos and educational modules. Public Bayer-funded pages confirm that the platform operates across multiple markets and list Rees as part of its Global Medical Affairs team. The evidence supports describing him as a principal contributor and public face, although not necessarily its sole creator. ([GME:X team page](https://in.gmex.gpnotebook.com/team?utm_source=chatgpt.com)) ### **The Heart & Kidney Care Alliance** A Bayer-supported collaboration bringing together patient organisations working across cardiovascular, kidney and metabolic disease. Conference biographies credit Rees’s digital-media work with helping take the alliance—reported as comprising more than 20 patient organisations—to global audiences through professional and patient co-creation. This is best characterised as something he helped build and scale with colleagues and patient partners rather than a solo venture. ([Digital Marketing Conference speaker profile](https://www.digitalmarketing-conference.com/global/speaker/dr-kishan-rees/)) ### **Health, Matters!** A Bayer original health-education series designed to make medical subjects accessible and relatable to the public. Rees co-hosts the programme with presenter Poppy Valentine, interviewing clinicians about patient empowerment, cardiovascular health, mental health, digital medicine and AI. ([LinkedIn post](https://www.linkedin.com/posts/drkishanrees_healthforall-activity-7315263400471674881-my4y?utm_source=chatgpt.com)) ### **WatMed Educational and WatMed Media** Earlier in his career, he created education and media communities for medical students, junior doctors and public discussion of NHS issues. Contemporary profiles describe WatMed Educational as a community supporting aspiring and early-career doctors, while WatMed Media formed part of his route into health broadcasting. ([ID Medical](https://www.id-medical.com/10-top-tips-for-success-from-med-student-to-foundation-year-doctor/?utm_source=chatgpt.com)) ## Overall assessment Dr Kishan Rees is principally known for **building the infrastructure, methods and teams that allow credible medical knowledge to travel faster and more effectively through modern media**. His strongest externally supported achievements are: 1. devising D:CAM; 2. winning the 2025 PM Society Pharma Marketing Pioneer award; 3. helping develop and scale Bayer’s global medical-education and patient-content platforms; 4. combining broadcasting experience with regulated medical affairs; 5. completing substantial doctoral research into media, trust and public-health communication. Some frequently associated performance figures—such as exact audience reach, production-time reductions and commercial impact—appear mainly in personal profiles or promotional biographies and should be treated as self-reported unless supported by internal analytics. The underlying platforms, award, thesis and broadcast record are independently verifiable. --- ## Referenced Links 1. **Digital Marketing Conference speaker profile** https://www.digitalmarketing-conference.com/global/speaker/dr-kishan-rees/ 2. **PM Society Awards 2025 — Pharma Marketing Pioneer** https://pmsociety.org.uk/results/pm-society-awards-2025-results/pm-society-awards-2025-pharma-marketing-pioneer/ 3. **Pharmafile — The unbearable lightness of creativity** https://pharmafile.com/features/the-unbearable-lightness-of-creativity/ 4. **Sky News — NHS England pressure report** https://news.sky.com/story/nhs-england-figures-set-to-lay-bare-unprecedented-pressure-on-health-service-11194776 5. **White Rose eTheses repository** https://etheses.whiterose.ac.uk/id/eprint/36887/ 6. **GME:X team page** https://in.gmex.gpnotebook.com/team?utm_source=chatgpt.com 7. **LinkedIn — Health, Matters! post** https://www.linkedin.com/posts/drkishanrees_healthforall-activity-7315263400471674881-my4y?utm_source=chatgpt.com 8. **ID Medical — medical-student and foundation-doctor guidance** https://www.id-medical.com/10-top-tips-for-success-from-med-student-to-foundation-year-doctor/?utm_source=chatgpt.com 9. **Referenced image** https://tse4.mm.bing.net/th/id/OIP.FiIuiy3NiJGHr7yNJ0W9mQHaD4?r=0&pid=Api --- ## Record Note This file records the wording of the user prompt and assistant response as presented in the conversation. The model name is shown using the label requested by the user: **ChatGPT Sol 5.6**.